Zelluna (OSE: ZLNA), a company pioneering allogeneic 'off-the-shelf' T Cell Receptor-based Natural Killer (TCR-NK) cell ...

Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, toda ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

A marine engineer has hailed its future prospects after a turnaround plan delivered a  “pivotal and highly productive year”. Tekmar Group… | Manufacturing | North East | International | Energy | Finan ...

This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused pipeline in ophthalmology.

Closing of additional $50 million tranche of $100 million equity private placement after achievement of clinical milestone ...

In 2018, educator Claire Jecklin led a team that launched the New Orleans Career Center with a mission to create pathways into “mid-skilled” careers in health care, construction and other sectors that ...

OQ Alternative Energy (OQAE) has reached major milestones across its Riyah 1, Riyah 2 and North Oman Solar projects, which are expected to be operational by the end of ...

Bitfarms Ltd. (NASDAQ/TSX: BITF), a North American digital infrastructure and energy company, today announced a series of strategic hires across ...